Drug-Drug Interaction Potentials of Tyrosine Kinase Inhibitors via Inhibition of UDP-Glucuronosyltransferases.

about

Suppression of carboxylesterases by imatinib mediated by the down-regulation of pregnane X receptor.Pharmacokinetic-Guided Dosing of New Oral Cancer Agents.Inhibition of UDP-Glucuronosyltransferase (UGT) Isoforms by Arctiin and Arctigenin.

P2860

Q38995804-0D05F9D9-6F68-49D4-A19D-8ECA63EA3912 Q47969048-A0898CA8-EB7B-4E19-AB94-678E67F3767B Q51345751-02A78AF6-CB83-4751-8B0A-D6FB3A9AC313

P2860

Drug-Drug Interaction Potentials of Tyrosine Kinase Inhibitors via Inhibition of UDP-Glucuronosyltransferases.

Item

http://www.wikidata.org/entity/Q36353657

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh

2015年學術文章

@zh-hant

name

Drug-Drug Interaction Potentia ...... UDP-Glucuronosyltransferases.

@ast

Drug-Drug Interaction Potentia ...... UDP-Glucuronosyltransferases.

@en

type

Item

label

Drug-Drug Interaction Potentia ...... UDP-Glucuronosyltransferases.

@ast

Drug-Drug Interaction Potentia ...... UDP-Glucuronosyltransferases.

@en

prefLabel

Drug-Drug Interaction Potentia ...... UDP-Glucuronosyltransferases.

@ast

Drug-Drug Interaction Potentia ...... UDP-Glucuronosyltransferases.

@en

P1476

Drug-Drug Interaction Potentia ...... UDP-Glucuronosyltransferases.

@en

P2093

Hyunyoung Jeong

http://www.w3.org/2001/XMLSchema#string

Nan Zhang

http://www.w3.org/2001/XMLSchema#string

Yong Liu

http://www.w3.org/2001/XMLSchema#string

P2860

Cloning of two human liver bilirubin UDP-glucuronosyltransferase cDNAs with expression in COS-1 cells

Simultaneous evaluation of six human glucuronidation activities in liver microsomes using liquid chromatography-tandem mass spectrometry

Tyrosine kinase - Role and significance in Cancer.

Differential expression of the UGT1A locus in human liver, biliary, and gastric tissue: identification of UGT1A7 and UGT1A10 transcripts in extrahepatic tissue

Pharmacokinetics of vandetanib: three phase I studies in healthy subjects

Phase I trial of the oral antiangiogenesis agent AG-013736 in patients with advanced solid tumors: pharmacokinetic and clinical results

Expression of the UDP-glucuronosyltransferase 1A locus in human colon. Identification and characterization of the novel extrahepatic UGT1A8

Database analyses for the prediction of in vivo drug-drug interactions from in vitro data.

Comparison of the drug-drug interactions potential of erlotinib and gefitinib via inhibition of UDP-glucuronosyltransferases.

Ageing populations: the challenges ahead.

P2888

srep17778

P304

17778

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/SREP17778

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-12-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

286413335

http://www.w3.org/2001/XMLSchema#string

P6179

1027104168

http://www.w3.org/2001/XMLSchema#string

P698

26642944

http://www.w3.org/2001/XMLSchema#string

P932

4672351

http://www.w3.org/2001/XMLSchema#string

Drug-Drug Interaction Potentials of Tyrosine Kinase Inhibitors via Inhibition of UDP-Glucuronosyltransferases.

about

P2860

P2860

Drug-Drug Interaction Potentials of Tyrosine Kinase Inhibitors via Inhibition of UDP-Glucuronosyltransferases.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P478

P577

P5875

P6179

P698

P932

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P478

P577

P5875

P6179

P698

P932